RT Journal Article
SR Electronic
T1 Learning from the COVID-19 pandemic: a systematic review of mathematical vaccine prioritization models
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.04.24303726
DO 10.1101/2024.03.04.24303726
A1 Gonzalez-Parra, Gilberto
A1 Mahmud, Md Shahriar
A1 Kadelka, Claus
YR 2024
UL http://medrxiv.org/content/early/2024/03/07/2024.03.04.24303726.abstract
AB As the world becomes ever more connected, the chance of pandemics increases as well. The recent COVID-19 pandemic and the concurrent global mass vaccine roll-out provides an ideal setting to learn from and refine our understanding of infectious disease models for better future preparedness. In this review, we systematically analyze and categorize mathematical models that have been developed to design optimal vaccine prioritization strategies of an initially limited vaccine. As older individuals are disproportionately affected by COVID-19, the focus is on models that take age explicitly into account. The lower mobility and activity level of older individuals gives rise to non-trivial trade-offs. Secondary research questions concern the optimal time interval between vaccine doses and spatial vaccine distribution. This review showcases the effect of various modeling assumptions on model outcomes. A solid understanding of these relationships yields better infectious disease models and thus public health decisions during the next pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementG.G.-P. acknowledges funding from Maria Zambrano (UPV, Ministry of Universities of Spain by the European Union-Next generation EU) and an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103451. C.K. was partially supported by a travel grant (712537) from the Simons Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript